New treatments for advanced kidney cancer have shown promising results but are unlikely to be adopted in the UK due to high costs. The National Institute for Health and Clinical Excellence has provisionally ruled out using four new drugs, citing cost-effectiveness concerns.
Researchers have discovered an experimental drug that successfully blocks an enzyme causing certain bone marrow cancers. The oral drug, CYT387, was tested in mice and human cells, blocking the growth of myeloproliferative disorders and normalizing blood counts.
A new study by the University of Illinois found that fructose metabolism is more complex than previously thought, inducing a broader range of genes in the liver. This can lead to increased glycogen and triglycerides in the liver, as well as insulin resistance.
New research from the University of Manchester has shown that even water-soluble statins can affect placental development, leading to worse pregnancy outcomes. Current guidelines recommend avoiding statins during pregnancy due to their potential risks, and this study supports these recommendations.
Researchers at the University of Illinois have developed self-healing coatings that can automatically repair themselves and prevent corrosion. The coatings use a dual capsule system to deliver a catalyst and healing agent, which react to fix damaged areas within minutes or hours.
Researchers at the University of Texas M. D. Anderson Cancer Center have developed a new three-drug combination therapy that spares patients from prolonged myelosuppression, a potentially lethal side effect of traditional treatments. The treatment achieved a remission rate of 96% in patients with indolent B cell lymphoma.
Researchers evaluated REVLIMID's clinical benefit in relapsed/refractory diffuse large B-cell lymphoma (DLBCL) patients, demonstrating improved response durations and safety profiles. The study's results support the use of REVLIMID as a treatment option for these patients.
A study found that dexamethasone effectively reduces postoperative nausea and vomiting after tonsillectomies, but also increases the risk of bleeding in children. The largest dose was associated with a nearly 7 times higher risk of bleeding.
A new study concludes that long-acting beta2-agonists (LABAs) offer no additional benefit to conventional preventative medications in children. LABAs, such as salmeterol and formoterol, can improve lung function but do not reduce asthma symptoms or hospital admissions.
A new study by NCAR and University of Colorado warns that developing countries will struggle to afford and implement efficient technologies, exacerbating global warming. The research suggests that even advanced nations are worsening the outlook for global warming due to increasing emissions.
Research by Philip Rodkin reveals that unpopular boys are more likely to bully popular girls, challenging the classic 'whipping boy' syndrome. The study found that both bullies and victims are highly disliked by their peers, highlighting the need for educators to take reports of harassment from popular girls seriously.
A Phase 2 clinical trial of pralatrexate found a complete or partial response in 27 percent of patients with recurrent or resistant peripheral T-cell lymphoma. The treatment, which mimics folic acid, showed durable responses in patients who had failed multiple prior treatments.
The European Society of Cardiology recommends echocardiography as the first-line test for patients suspected of cardiovascular disease. Echocardiography provides accurate images of the heart's chambers, valves, and coronary arteries, allowing for diagnosis and prognosis without invasive procedures.
Professor Hamid Hadim has received a grant to develop an introductory level training course on pressurized water reactor nuclear power plants. The course will provide EPRI staff with better understanding of fundamental principles and design methodologies, enabling more valuable research and development.
A subset analysis of the AZA-001 trial demonstrated that Vidaza significantly improved overall survival in patients with WHO-defined acute myeloid leukemia (AML) compared to conventional care regimens. The study also showed reduced infections, hospitalizations, and red blood cell transfusions.
SMU chemist Brent Sumerlin has received a $475,000 NSF Faculty Early Career Development Award for two related nanotechnology research projects. His work focuses on developing novel materials with composite properties, including automatic insulin release technology for diabetics and self-repairing coatings for airplane wings.
Researchers found that siblings with mental illnesses are 63% more likely to experience depressive episodes, while those with low IQs are 18% more likely to live near their sibling but have lower emotional attachment. Environmental and social factors also play a role in poor mental health among these siblings.
A leading academic from Durham University argues that patients must comply with moral duties to look after themselves and others when accessing free healthcare. This includes promoting one's own health, using NHS resources responsibly, and cooperating with medical advice and treatment.
A new spinal deformity classification system has been developed to define the range of normalcy for spine alignment. The system, published in Neurosurgery, uses a systematic approach to define neutral upright spinal alignment across different age groups.
Two studies estimate the economic burden of cancer mortality using lost years of work and willingness-to-pay approaches. The estimated cost of cancer mortality in the US is high, with lung cancer accounting for 25% or more of costs.
A study found that most unintentional overdose deaths in West Virginia were associated with the nonmedical use and diversion of pharmaceuticals, primarily pain relievers. The majority of decedents had a history of substance abuse and used multiple contributory substances.
A recent study found that powerful individuals make better decisions when they engage in unconscious thinking, similar to the way most people process information. The research suggests that having power changes how people think and approach complex decision-making.
The University of Delaware is part of an international team building the IceCube neutrino telescope, which will study high-energy cosmic events. The $150 million project will detect neutrinos passing through the Antarctic ice, opening new insights into astrophysics.
Studies show Keppra XR reduces nervous system side effects compared to levetiracetam immediate release, and a new dosing schedule may offer improved tolerability. The once-daily formulation also demonstrates bioequivalence in healthy adults.
A major study of over 14,000 male physicians found that long-term vitamin E and C supplementation had no significant impact on prostate cancer or total cancer risk. The study suggests that these supplements may not be effective in preventing cancer in middle-aged and older men.
A new combination of medications has improved or stabilized disease in 76% of patients with relapsed multiple myeloma. Pomalidomide combined with dexamethasone showed promising results, with minimal side effects.
An analysis of a phase III clinical trial showed that VIDAZA can improve patient responses, achieving an overall response rate of 51% in higher-risk MDS patients. Continued treatment with VIDAZA led to better outcomes for almost half of responders.
Researchers have developed a transparent resistive random access memory (TRRAM) chip, enabling see-through electronic systems. The technology may drive new directions in electronics, allowing for more compact devices and cheaper manufacturing.
A team of Princeton researchers found that molybdenum is crucial for controlling the biological conversion of nitrogen in tropical rainforests, supporting plant growth. The discovery has implications for global climate change policy, as it may limit the amount of carbon dioxide that tropical rainforests can absorb.
A review of nine clinical trials found that cholinesterase inhibitors significantly reduced behavioral symptoms like aggression, wandering, and paranoia in Alzheimer's disease patients. The medications are safe and produce no major side effects, making them a potential alternative to antipsychotic drugs.
Research by University of Chicago psychologist Sian L. Beilock reveals that math anxiety can be debilitating due to the consumption of working memory resources by worries and stereotypes. Individuals with higher working memory capacity are more prone to 'choke under pressure' when stressed.
Smokers carrying a specific gene variant are more susceptible to concentration problems and cognitive deficits during abstinence, increasing the risk of relapse. The study paves the way for novel medications to treat nicotine addiction.
Researchers estimate RASD affects 25-30% of children with an autistic disorder. Children with RASD typically develop normally until 18-24 months, then regress and lose previously acquired skills. Identifying early signs is crucial to address potential neurological development issues.
Early investigational studies show anti-tumor activity in ZOLINZA (vorinostat) and bortezomib combination for relapsed or refractory multiple myeloma. Clinical trials are underway to further evaluate this combination, offering new hope for advanced multiple myeloma patients.
Scientists have obtained the first 3D images of the Mcm10 protein, which is essential for DNA replication in eukaryotic cells. The structure reveals unique features that allow it to interact with single-stranded DNA and position other proteins on the DNA strand.
The study found an ORR of 53% and CR/CRu of 20% in evaluable patients, while pooled data showed a 57% ORR and 21% CR. REVLIMID is being evaluated as a treatment option for heavily pretreated MCL patients.
The Lancet report identifies key right-to-health features and indicators, highlighting gaps in data and progress towards universal access to healthcare. The study emphasizes the importance of non-discrimination, mental health allocation, and health information availability.
A genetic modification has prolonged the life of mice with amyotrophic lateral sclerosis (ALS) by boosting antioxidant production. The discovery offers new hope for treating ALS and other neurodegenerative diseases.
Researchers at University of Leeds have identified a promising new target for hepatitis C treatment: the p7 protein. The study found that genetic variations among HCV strains affect sensitivity to certain drugs, highlighting the need for tailored combination treatments.
Researchers found that unconscious thought was not always effective in making the best choices. Instead, thinking about a decision at one's own pace and focusing on the problem led to larger payoffs. The study suggests that relying on self-paced conscious thought can be a more reliable approach for complex decisions.
A large cancer prevention trial found no association between supplementation with vitamin E or selenium and a reduced risk of prostate cancer. The study included 35,533 men and followed them for up to 7 years, concluding that these supplements were ineffective in preventing prostate cancer.
Researchers are fitting lobsters with transmitters to track their migrations year-round, providing more accurate information about juvenile lobster sources and interactions between populations. The study aims to improve management of the economically valuable fishery, allowing lobsters to remain a staple in New England cuisine.
Researchers at the University of Calgary found that tropical regions have higher risks of plant extinction than previously thought. The study analyzed worldwide databases and discovered that factors like latitude are more important in determining the number of threatened species than human activities.
A recent study published in Redox Report reveals that Pycnogenol significantly lowers plasma levels of C-reactive protein (CRP) in osteoarthritis patients. This finding suggests that Pycnogenol's anti-inflammatory potency may be potent enough to arrest the spread of inflammation from osteoarthritic joints to the whole organism.
A recent study by Rensselaer Polytechnic Institute suggests that non-conscious exposure to advertisements can increase consumer preference for promoted products. The research, led by cognitive scientist Mark Changizi, reveals how advertising tactics like apparel branding and product placement in movies and TV shows tap into our brain's...
A new US-UK study reveals that people in both countries hold positive views of nanotechnologies, with a focus on energy applications. The research found that participants were more optimistic about the future contribution of new technologies to society and exhibited a high degree of comfort with energy applications.
Scientists present reports on novel technologies to restore memory circuits, alter drug effects, deliver targeted therapies and improve brain imaging. The advancements aim to pinpoint seizure causes and deliver precise treatments, promising a new era in epilepsy care.
A meta-analysis of decades-long experimental evidence reveals that modern day concentrations of ground level ozone pollution are decreasing tree growth in northern and temperate mid-latitudes. The study predicts a 17% reduction in tree growth by the end of the century if current fossil fuel dependence continues.
A study published by researchers at M.D. Anderson Cancer Center revealed that intense chemotherapy significantly reduces the risk of recurrence in young mantle cell lymphoma patients. In a median follow-up of seven years, 52% of patients aged 65 or younger achieved disease-free survival.
The Tree Carbon Calculator provides quantifiable incentives for tree planting and stewardship projects. It calculates the dry weight of biomass that would be obtained if a tree were removed, offering a valuable resource for urban forestry efforts.
Researchers at UCSF Ernest Gallo Clinic and Research Center have identified a DNA sequence variation on chromosome 15 associated with the level of response to alcohol. This finding could signal the genetic factors that affect alcohol abuse, and may help develop targeted treatments.
A University of Illinois study found that honey, rich in antioxidants, protects the quality of salad dressings for up to nine months while naturally sweetening them. The study substituted honey for chemical additives and high-fructose corn syrup, resulting in a healthier alternative.
Researchers found that among women under 40, black women have a higher breast cancer incidence rate than white women. However, this trend reverses among women over 40, with white women having a higher incidence rate. The study confirms the age-related crossover effect in breast cancer incidence rates between black and white ethnic groups.
The American College of Medical Genetics recommends offering genetic test for SMA to all couples, regardless of family history. The goal is to identify carriers and provide early testing options, while ensuring informed consent and access to reproductive resources.
Researchers at NPL developed magnetic semiconductors with superior performance, showing potential for electronic devices. The technology could revolutionize computing and be realized in 10 years, sustaining Moore's Law.
The American College of Toxicology partnered with SAGE to publish the International Journal of Toxicology, a peer-reviewed bi-monthly journal covering current research in toxicology. The journal will increase visibility globally and provide access to full-text articles through SAGE Journals Online.
Researchers found that economic incentives, such as lottery-based groups and deposit contracts, were highly effective in inducing initial weight loss. The study's results showed a significant difference in weight loss between the incentive groups and the control group.
Researchers at Children's Hospital of Philadelphia found that overweight siblings of children with type 2 diabetes are four times more likely to have abnormal glucose levels. This discovery highlights the importance of screening and prevention education for these high-risk individuals.
A meta-analysis of 128 clinical trials has found that nonhormonal treatment regimens, including anthracycline-based regimens and taxanes, have improved overall survival in women with advanced breast cancer. The use of these regimens led to a significant relative risk reduction in overall mortality.